Buccal cell cytokeratin 14 identifies mild cognitive impairment and alzheimer’s disease in the AIBL study of aging

Current Alzheimer Research

Volumn 12, Issue 3, 2015, Pages 233-241

  Leifert, Wayne R ^a   Tuli, Jannatul Ferdoush ^a   François, Maxime ^a   Nguyen, Tori ^a   Rembach, Alan ^b   Rumble, Rebecca L ^b   Rainey Smith, Stephanie ^c   Martins, Ralph ^c   Fenech, Michael F ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c EDITH COWAN UNIVERSITY   (Australia)

Author keywords

AIBL; Alzheimer s disease; Buccal cells; Cytokeratin; Homocysteine; Immunofluorescence

Indexed keywords

APOLIPOPROTEIN E4; BIOLOGICAL MARKER; CYTOKERATIN 14; HOMOCYSTEINE;

ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CHEEK CELL; CHEEK MUCOSA; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MILD COGNITIVE IMPAIRMENT; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; AGED; AGING; GENETICS; METABOLISM; MOUTH MUCOSA; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; FEMALE; HUMANS; KERATIN-14; MALE; MILD COGNITIVE IMPAIRMENT; MOUTH MUCOSA; ROC CURVE;

EID: 84928981292     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205012666150302154650     Document Type: Article

References (47)

1. Francois M, Leifert W, Martins R, Thomas P, Fenech M. Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells. Curr Alzheimer Res 11: 519-531 (2014).
2. Francois M, Leifert W, Hecker J, Faunt J, Martins R, Thomas P, et al.Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. Cytometry A 85A(8): 698-708 (2014).
3. Leifert WR, Francois M, Thomas P, Luther E, Holden E, Fenech M. Automation of the buccal micronucleus cytome assay using laser scanning cytometry. Methods Cell Biol 102: 321-339 (2011).
4. Thomas P, O'Callaghan NJ, Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev 129(4): 183-190 (2008).
5. Thomas P, Hecker J, Faunt J, Fenech M. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease. Mutagenesis 22(6): 371-379 (2007).
6. Thomas P, Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, et al.Buccal micronucleus cytome assay. Nat Protoc 4(6): 825-837 (2009).
7. Hosoya A, Lee JM, Cho SW, Kim JY, Shinozaki N, Shibahara T, et al.Morphological evidence of basal keratinocyte migration during the re-epithelialization process. Histochem Cell Biol 130(6): 1165-1175 (2008).
8. Lavker RM, Sun TT. Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations. Science 215(4537): 1239-1241 (1982).
9. Purkis PE, Steel JB, Mackenzie IC, Nathrath WB, Leigh IM, Lane EB. Antibody markers of basal cells in complex epithelia. J Cell Sci 97 (Pt 1)(Pt 1): 39-50 (1990).
10. Zampetti M, Fattorossi A, Grieco T, Calvieri S. Basal keratinocyte subsets: ultrastructural and morphometric features. Acta Derm Venereol 69(1): 59-62 (1989).
11. Kaur P, Li A. Adhesive properties of human basal epidermal cells: an analysis of keratinocyte stem cells, transit amplifying cells, and postmitotic differentiating cells. J Invest Dermatol 114(3): 413-420 (2000).
12. Anderton BH. Intermediate filaments: a family of homologous structures. J Muscle Res Cell Motil 2(2): 141-166 (1981).
13. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31(1): 11-24 (1982).
14. Tseng SC, Jarvinen MJ, Nelson WG, Huang JW, Woodcock- Mitchell J, Sun TT. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 30(2): 361-372 (1982).
15. Vaidya MM, Borges AM, Pradhan SA, Rajpal RM, Bhisey AN. Altered keratin expression in buccal mucosal squamous cell carcinoma. J Oral Pathol Med 18(5): 282-286 (1989).
16. Clausen H, Moe D, Buschard K, Dabelsteen E. Keratin proteins in human oral mucosa. J Oral Pathol 15(1): 36-42 (1986).
17. Banks-Schlegel SP. Keratin alterations during embryonic epidermal differentiation: a presage of adult epidermal maturation. J Cell Biol 93(3): 551-559 (1982).
18. Moll R, Moll I, Wiest W. Changes in the pattern of cytokeratin polypeptides in epidermis and hair follicles during skin development in human fetuses. Differentiation 23(2): 170-178 (1982).
19. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 95(2 Pt 1): 580-588 (1982).
20. Sun TT, Eichner R, Nelson WG, Tseng SC, Weiss RA, Jarvinen M, et al.Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol 81(1): 109s-15s (1983).
21. Clausen H, Vedtofte P, Moe D, Dabelsteen E. Keratin pattern in human and buccal and hard palate mucosa. Scand J Dent Res 91(5): 411-413 (1983).
22. Breitkreutz D, Bohnert A, Herzmann E, Bowden PE, Boukamp P, Fusenig NE. Differentiation specific functions in cultured and transplanted mouse keratinocytes: environmental influences on ultrastructure and keratin expression. Differentiation 26(2): 154-169 (1984).
23. Schweizer J, Winter H, Hill MW, Mackenzie IC. The keratin polypeptide patterns in heterotypically recombined epithelia of skin and mucosa of adult mouse. Differentiation 26(2): 144-153 (1984).
24. Steinert PM, Peck GL, Idler WW. Structural changes of human epidermal alpha-keratin in disorders of keratinization. Curr Probl Dermatol 10: 391-406 (1980).
25. Loning T, Staquet MJ, Thivolet J, Seifert G. Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol 388(3): 273-288 (1980).
26. Staquet MJ, Viac J, Thivolet J. Keratin polypeptide modifications induced by human papilloma viruses (HPV). Arch Dermatol Res 271(1): 83-90 (1981).
27. Matoltsy AG, Matoltsy MN, Cliffel PJ. Characterization of keratin polypeptides of normal and psoriatic horny cells. J Invest Dermatol 80(3): 185-188 (1983).
28. Bowden PE, Wood EJ, Cunliffe WJ. Comparison of prekeratin and keratin polypeptides in normal and psoriatic human epidermis. Biochim Biophys Acta 743(1): 172-179 (1983).
29. Winter H, Schweizer J, Goerttler K. Keratin polypeptide composition as a biochemical tool for the discrimination of benign and malignant epithelial lesions in man. Arch Dermatol Res 275(1): 27-34 (1983).
30. Weiss RA, Eichner R, Sun TT. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 98(4): 1397-1406 (1984).
31. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, et al.The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21(4): 672-687 (2009).
32. Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, et al.Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease. Arch Neurol 1-8 (2012).
33. Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, et al.Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. J Alzheimers Dis 27(4): 909-922 (2011).
34. Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, et al.Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology 76(12): 1091-1098 (2011).
35. DeWitt DA, Silver J. Regenerative failure: a potential mechanism for neuritic dystrophy in Alzheimer's disease. Exp Neurol 142(1):103-110 (1996).
36. Winning TA, Townsend GC. Oral mucosal embryology and histology. Clin Dermatol 18(5): 499-511 (2000).
37. Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 29: 7-15 (2001).
38. Hill MW. Epithelial proliferation and turn over in oral epithelia and epidermis with age. The Effect of Ageing in the Oral Mucosa and Skin. London (UK): Bocca Raton: CRC Press pp. 75-83 (1994).
39. Hill MW. The structural aspects of ageing in the oral mucosa. The Effect of Ageing in the Oral Mucosa and Skin. London (UK): Bocca Raton: CRC Press pp. 65-74 (1994).
40. Moragas A, Castells C, Sans M. Mathematical morphologic analysis of aging-related epidermal changes. Anal Quant Cytol Histol 15(2): 75-82 (1993).
41. Hull MT, Warfel KA. Age-related changes in the cutaneous basal lamina: scanning electron microscopic study. J Invest Dermatol 81(4): 378-380 (1983).
42. Thomas DR. Age-related changes in wound healing. Drugs Aging 18(8): 607-620 (2001).
43. de Oliveira RM, Lia EN, Guimaraes RM, Bocca AL, Cavalcante Neto FF, da Silva TA. Cytologic and cytometric analysis of oral mucosa in Alzheimer's disease. Anal Quant Cytol Histol 30(2): 113-118 (2008).
44. Lueck NE, Robinson RA. High levels of expression of cytokeratin 5 are strongly correlated with poor survival in higher grades of mucoepidermoid carcinoma. J Clin Pathol 61(7): 837-840 (2008).
45. Thambisetty M, Lovestone S. Blood-based biomarkers of Alzheimer's disease: challenging but feasible. Biomark Med 4(1): 65-79 (2010).
46. Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, et al.Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry 64(3): 298-305 (1998).
47. Blennow K, Zetterberg H. Cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 18(2): 413-417 (2009).